AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34407273 — intervention group
Group type: EXPERIMENTAL
Intervention: Cotrimoxazole (CTX)
Number of subjects: 193
Study 34407273 — intervention group
Group type: COMPARATOR
Intervention: Sulfadoxine-pyrimethamine (IPTp-SP)
Number of subjects: 193
Study 32095887 — intervention group
Group type: EXPERIMENTAL
Intervention: MindMotion™GO exergame therapy for 30 minutes
Number of subjects: 10
Study 35075067 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental treatment using a BCI prototype with audio-visual entrainment
Number of subjects: 15
Study 35075067 — intervention group
Group type: COMPARATOR
Intervention: Active control
Number of subjects: 15
Study 35182037 — intervention group
Group type: EXPERIMENTAL
Intervention: Cenobamate 200 mg/day
Number of subjects: 108
Study 35182037 — intervention group
Group type: EXPERIMENTAL
Intervention: Cenobamate 500 mg/day
Number of subjects: 108
Study 35182037 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg (positive control)
Number of subjects: 108
Study 35182037 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study 33973891 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrinogen concentrate (FCH)
Number of subjects: 152
Study 33973891 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152
Study 33361162 — intervention group
Group type: EXPERIMENTAL
Intervention: Active transcranial direct current stimulation (tDCS) at 2 mA for 20 min for 10 sessions over five consecutive days.
Number of subjects: 46
Study 33361162 — intervention group
Group type: COMPARATOR
Intervention: Sham transcranial direct current stimulation (stimulation ramped up and down for 1 min) for 10 sessions over five consecutive days.
Number of subjects: 46
Study 33361162 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 46
Study 33361162 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 46
Study 34283380 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily micro-surveys administered via smartphone application
Number of subjects: 95
Study 34283380 — intervention group
Group type: COMPARATOR
Intervention: Full-length SF-36 administered preoperatively and at 4, 12, and 24 weeks postoperatively
Number of subjects: 95
Study 34283380 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily micro-surveys
Number of subjects: 95
Study 34053159 — intervention group
Group type: EXPERIMENTAL
Intervention: Midline catheters
Number of subjects: 110
Study 34053159 — intervention group
Group type: COMPARATOR
Intervention: Peripherally inserted central catheters
Number of subjects: 110
Study 35033562 — intervention group
Group type: EXPERIMENTAL
Intervention: NICU2HOME app (intervention)
Number of subjects: 298
Study 35033562 — intervention group
Group type: EXPERIMENTAL
Intervention: Average app usage
Number of subjects: 298
Study 34849019 — intervention group
Group type: EXPERIMENTAL
Intervention: 40mg chloroprocaine with 5 mcg spinal dexmedetomidine (Spinal Dexgroup)
Number of subjects: 135
Study 34849019 — intervention group
Group type: COMPARATOR
Intervention: 40mg chloroprocaine (Chloro-group)
Number of subjects: 135
Study 34849019 — intervention group
Group type: COMPARATOR
Intervention: 40mg chloroprocaine with 0.5 mcg/kg IV dexmedetomidine (IV DEXgroup)
Number of subjects: 135
Study 35184665 — intervention group
Group type: EXPERIMENTAL
Intervention: Alzheimer's Cafè (AC) cognitive-behavior training
Number of subjects: 20
Study 35184665 — intervention group
Group type: COMPARATOR
Intervention: Conventional cognitive training
Number of subjects: 20
Study 33712844 — intervention group
Group type: EXPERIMENTAL
Intervention: SMARThealth intervention
Number of subjects: 0
Study 33712844 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 35282049 — intervention group
Group type: EXPERIMENTAL
Intervention: Loose combined cutting seton (LCCS)
Number of subjects: 0
Study 35282049 — intervention group
Group type: COMPARATOR
Intervention: Incision and drainage
Number of subjects: 0
Study 33351652 — intervention group
Group type: COMPARATOR
Intervention: Lethal means counseling
Number of subjects: 232
Study 33351652 — intervention group
Group type: COMPARATOR
Intervention: Provision of cable locks
Number of subjects: 232
Study 34570053 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led web-based health management program for 6 months
Number of subjects: 112
Study 34564744 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics signature based on pre-treatment CT scans
Number of subjects: 322
Study 34564744 — intervention group
Group type: EXPERIMENTAL
Intervention: Refined radiomics signature after identifying six independent predictive features
Number of subjects: 322
Study 36494261 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-dose S1
Number of subjects: 160
Study 36494261 — intervention group
Group type: COMPARATOR
Intervention: Reduced-dose S1 + oxaliplatin
Number of subjects: 160
Study 36494261 — intervention group
Group type: EXPERIMENTAL
Intervention: ECOG PS
Number of subjects: 160
Study 36494261 — intervention group
Group type: EXPERIMENTAL
Intervention: G8
Number of subjects: 160
Study 36494261 — intervention group
Group type: EXPERIMENTAL
Intervention: VES-13
Number of subjects: 160
Study 36494261 — intervention group
Group type: EXPERIMENTAL
Intervention: Frailty phenotype
Number of subjects: 160
Study 33593336 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-conducted education and follow-up
Number of subjects: 200
Study 33593336 — intervention group
Group type: COMPARATOR
Intervention: Standard nursing counseling
Number of subjects: 200
Study 33127634 — intervention group
Group type: EXPERIMENTAL
Intervention: Study definition of hyperkalaemia (serum potassium >5.5 mEq/L)
Number of subjects: 1266
Study 33127634 — intervention group
Group type: EXPERIMENTAL
Intervention: Study definition of hypokalaemia (serum potassium <3.5 mEq/L)
Number of subjects: 1266
Study 33127634 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk of hyperkalaemia associated with unhealthy conditions
Number of subjects: 1266
Study 33127634 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk of hypokalaemia associated with unhealthy conditions
Number of subjects: 1266
Study 33127634 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk of hypokalaemia associated with older age
Number of subjects: 1266
Study 33127634 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk of hypokalaemia associated with region
Number of subjects: 1266
Study 33127634 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher serum potassium associated with male gender
Number of subjects: 1266
Study 33127634 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher serum potassium associated with estimated glomerular filtration rate <60 mL/min/1.73 m2
Number of subjects: 1266
Study 33127634 — intervention group
Group type: EXPERIMENTAL
Intervention: Guidelines definition of hyperkalaemia
Number of subjects: 1266
Study 33127634 — intervention group
Group type: EXPERIMENTAL
Intervention: Guidelines definition of hypokalaemia
Number of subjects: 1266
Study 35378105 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional training (24 one-hour sessions, three times a week, moderate intensity equivalent to 6-7 on the Borg scale)
Number of subjects: 25
Study 35378105 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional training
Number of subjects: 25
Study 32481241 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT) applied paraspinal alongside a physical exercise program (3 times/week for 3 months)
Number of subjects: 45
Study 34115318 — intervention group
Group type: EXPERIMENTAL
Intervention: Lact. reuteri LR-99 probiotic (6 × 10^10 colony forming units)
Number of subjects: 71
Study 34115318 — intervention group
Group type: EXPERIMENTAL
Intervention: Lact. reuteri LR-99 probiotic
Number of subjects: 71
Study 32347692 — intervention group
Group type: EXPERIMENTAL
Intervention: FineVision toric PODFT (PhysIOL)
Number of subjects: 60
Study 32347692 — intervention group
Group type: COMPARATOR
Intervention: Acrysof IQ PanOptix toric (Alcon)
Number of subjects: 60
Study 35426564 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir
Number of subjects: 11
Study 33785233 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent traction with vibration (ITV)
Number of subjects: 95
Study 33785233 — intervention group
Group type: COMPARATOR
Intervention: Intermittent traction only (ITO)
Number of subjects: 95
Study 36101719 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-based delivery (SPBD) of written educational materials
Number of subjects: 104
Study 36101719 — intervention group
Group type: COMPARATOR
Intervention: Routine print delivery (PD) of educational materials
Number of subjects: 104
Study 33103819 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketogenic medium chain triglyceride (kMCT) drink; 15 g twice/day
Number of subjects: 83
Study 35126621 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow oxygen therapy
Number of subjects: 120
Study 35126621 — intervention group
Group type: COMPARATOR
Intervention: Traditional oxygen therapy
Number of subjects: 120
Study 34034362 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-married participants
Number of subjects: 1171
Study 34034362 — intervention group
Group type: COMPARATOR
Intervention: Married participants
Number of subjects: 1171
Study 32370906 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 33217236 — intervention group
Group type: EXPERIMENTAL
Intervention: PIT + PT
Number of subjects: 50
Study 33217236 — intervention group
Group type: COMPARATOR
Intervention: PT
Number of subjects: 50
Study 32065827 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning-derived early warning system (n=34)
Number of subjects: 68
Study 32065827 — intervention group
Group type: COMPARATOR
Intervention: Standard care (n=34)
Number of subjects: 68
Study 34291275 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MedDiet) intervention
Number of subjects: 826
Study 34291275 — intervention group
Group type: COMPARATOR
Intervention: Control group (no MedDiet)
Number of subjects: 826
Study 34291275 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher baseline kynurenine:tryptophan ratio
Number of subjects: 826
Study 34291275 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levels of kynurenic acid
Number of subjects: 826
Study 34291275 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinolinic acid
Number of subjects: 826
Study 34291275 — intervention group
Group type: EXPERIMENTAL
Intervention: Kynurenic acid
Number of subjects: 826
Study 32164382 — intervention group
Group type: EXPERIMENTAL
Intervention: DVB-PVP cartridge
Number of subjects: 0
Study 32164382 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of synbiotic treatment with DVB-PVP HD
Number of subjects: 0
Study 32164382 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0
Study 34968662 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-microbial soap
Number of subjects: 30
Study 34968662 — intervention group
Group type: COMPARATOR
Intervention: Placebo soap
Number of subjects: 30
Study 32800969 — intervention group
Group type: EXPERIMENTAL
Intervention: Yokukansan
Number of subjects: 195
Study 32800969 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 195
Study 32791792 — intervention group
Group type: EXPERIMENTAL
Intervention: Portal vein thrombosis (PVT) group
Number of subjects: 398
Study 616625517 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D CT overlay
Number of subjects: 30
Study 616625517 — intervention group
Group type: COMPARATOR
Intervention: Contrast pulmonary venography
Number of subjects: 30
Study 34115660 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold Forceps (CF)
Number of subjects: 353
Study 34115660 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold Snare (CS)
Number of subjects: 353
Study 34115660 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot Snare (HS)
Number of subjects: 353
Study 33501902 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised placement and support programme integrated with a personalised pain management plan.
Number of subjects: 50
Study 33501902 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised placement and support programme
Number of subjects: 50
Study 33501902 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 50
Study 33501902 — intervention group
Group type: COMPARATOR
Intervention: Recruitment methods
Number of subjects: 50
Study 33501902 — intervention group
Group type: COMPARATOR
Intervention: Retention of participants
Number of subjects: 50
Study 33661810 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 Hz visual stimulation
Number of subjects: 28
Study 33661810 — intervention group
Group type: COMPARATOR
Intervention: 7 Hz visual stimulation
Number of subjects: 28
Study 36147581 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptives (combined formulations containing ethinyl estradiol 10-35 ug/day plus a synthetic progestin) during the active phase of OC use.
Number of subjects: 201
Study 36147581 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptives (combined formulations containing ethinyl estradiol 10-35 ug/day plus a synthetic progestin) during the inactive phase of OC use.
Number of subjects: 201
Study 36147581 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptives containing first- or second-generation progestins (the estrane family of progestins or OCs containing levonorgestrel).
Number of subjects: 201
Study 36147581 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptives containing recently developed progestins and lower doses of ethinyl estradiol.
Number of subjects: 201
Study 36147581 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptives (various brands classified by estrogenic strength).
Number of subjects: 201
Study 33813930 — intervention group
Group type: EXPERIMENTAL
Intervention: Sound intervention
Number of subjects: 52
Study 33813930 — intervention group
Group type: COMPARATOR
Intervention: Rest
Number of subjects: 52
Study 32643265 — intervention group
Group type: EXPERIMENTAL
Intervention: Sub-threshold nano-second laser (SNL) treatment
Number of subjects: 50
Study 32643265 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 50
Study 36205250 — intervention group
Group type: EXPERIMENTAL
Intervention: Microbial inoculant (Lactococcus lactis 0224 and Lactobacillus buchneri LB1819)
Number of subjects: 48
Study 36205250 — intervention group
Group type: EXPERIMENTAL
Intervention: Bale moisture at 64.1%
Number of subjects: 48
Study 36205250 — intervention group
Group type: COMPARATOR
Intervention: Control (no manure)
Number of subjects: 48
Study 36205250 — intervention group
Group type: COMPARATOR
Intervention: Slurry applied immediately to stubble (63,250 L/ha)
Number of subjects: 48
Study 36205250 — intervention group
Group type: COMPARATOR
Intervention: Slurry applied after a 1-wk delay (57,484 L/ha)
Number of subjects: 48
Study 36205250 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exposure period (34 days)
Number of subjects: 48
Study 34535130 — intervention group
Group type: EXPERIMENTAL
Intervention: Malaria prevention and elimination strategies implemented in Dembiya district.
Number of subjects: 735
Study 34535130 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent outdoor activity
Number of subjects: 735
Study 34535130 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness about malaria transmission
Number of subjects: 735
Study 34854987 — intervention group
Group type: COMPARATOR
Intervention: RCT (Root Canal Therapy)
Number of subjects: 157
Study 34854987 — intervention group
Group type: EXPERIMENTAL
Intervention: PMTA (Pulpotomy with ProRoot MTA)
Number of subjects: 157
Study 34854987 — intervention group
Group type: EXPERIMENTAL
Intervention: PCEM (Pulpotomy with CEM cement)
Number of subjects: 157
Study 32693009 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent exercise program
Number of subjects: 126
Study 32693009 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-task training
Number of subjects: 126
Study 32693009 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking program
Number of subjects: 126
Study 33599975 — intervention group
Group type: EXPERIMENTAL
Intervention: Blonanserin transdermal patch
Number of subjects: 441
Study 35948966 — intervention group
Group type: EXPERIMENTAL
Intervention: Flashing light (Flash)
Number of subjects: 10
Study 35948966 — intervention group
Group type: EXPERIMENTAL
Intervention: Darkness (Dark)
Number of subjects: 10
Study 33416202 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT Raising Safe Kids parenting program
Number of subjects: 143
Study 34131766 — intervention group
Group type: EXPERIMENTAL
Intervention: FRACTING score ≥ 7 at the immediate post-operative period
Number of subjects: 15
Study 34131766 — intervention group
Group type: EXPERIMENTAL
Intervention: LEG‐NUI score ≥ 5 within 12 weeks
Number of subjects: 15
Study 34131766 — intervention group
Group type: EXPERIMENTAL
Intervention: NURD score ≥ 9 at the immediate post-operative period
Number of subjects: 15
Study 34131766 — intervention group
Group type: EXPERIMENTAL
Intervention: TFHS < 3 at 12 weeks
Number of subjects: 15
Study 36372315 — intervention group
Group type: EXPERIMENTAL
Intervention: AuriAc (AEFI-specific auricular points applied, n = 52)
Number of subjects: 147
Study 36372315 — intervention group
Group type: COMPARATOR
Intervention: SAuriAc (sham auricular acupressure, n = 51)
Number of subjects: 147
Study 36372315 — intervention group
Group type: COMPARATOR
Intervention: TrAsU (treatment as usual, n = 44)
Number of subjects: 147
Study 33280425 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin degludec
Number of subjects: 7637
Study 33280425 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine 100 units/mL (glargine U100)
Number of subjects: 7637
Study 33280425 — intervention group
Group type: EXPERIMENTAL
Intervention: History of heart failure
Number of subjects: 7637
Study 33280425 — intervention group
Group type: EXPERIMENTAL
Intervention: History of hepatic impairment
Number of subjects: 7637
Study 36221341 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy (acupuncture and moxibustion)
Number of subjects: 200
Study 36221341 — intervention group
Group type: COMPARATOR
Intervention: Conventional western medicine
Number of subjects: 200
Study 34477306 — intervention group
Group type: EXPERIMENTAL
Intervention: AI-assisted colonoscopy
Number of subjects: 2352
Study 34477306 — intervention group
Group type: COMPARATOR
Intervention: Conventional colonoscopy (control group)
Number of subjects: 2352
Study 32776649 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical Insufflator-Exsufflator (MI-E)
Number of subjects: 22
Study 32776649 — intervention group
Group type: COMPARATOR
Intervention: Autogenic Drainage (AD)
Number of subjects: 22
Study 34608048 — intervention group
Group type: COMPARATOR
Intervention: Usual physical activity (control)
Number of subjects: 20
Study 35157299 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast Track Surgery (FTS) protocol
Number of subjects: 30
Study 35157299 — intervention group
Group type: COMPARATOR
Intervention: Standard protocol
Number of subjects: 30
Study 32233095 — intervention group
Group type: EXPERIMENTAL
Intervention: Daunorubicin (DNR, 50 mg/m2) with standard-dose cytarabine and etoposide for induction chemotherapy and intermediate dose cytarabine for consolidation
Number of subjects: 2157
Study 32233095 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitoxantrone (MXR, 12 mg/m2) with standard-dose cytarabine and etoposide for induction chemotherapy and intermediate dose cytarabine for consolidation
Number of subjects: 2157
Study 32233095 — intervention group
Group type: EXPERIMENTAL
Intervention: Idarubicin (IDA, 10 mg/m2) with standard-dose cytarabine and etoposide for induction chemotherapy and intermediate dose cytarabine for consolidation
Number of subjects: 2157
Study 32233095 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic hematopoietic stem cell transplantation (HSCT) for patients with a HLA-identical sibling donor
Number of subjects: 2157
Study 32233095 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous HSCT for patients without a HLA-identical sibling donor
Number of subjects: 2157
Study 34099268 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy (30-minute session)
Number of subjects: 60
Study 34099268 — intervention group
Group type: COMPARATOR
Intervention: Control group (no music session)
Number of subjects: 60
Study 32990633 — intervention group
Group type: COMPARATOR
Intervention: Standard group with automated emails (S)
Number of subjects: 605
Study 32990633 — intervention group
Group type: COMPARATOR
Intervention: Standard plus personalized SMS (S+pSMS)
Number of subjects: 605
Study 32990633 — intervention group
Group type: COMPARATOR
Intervention: Standard plus weekly videoconferencing support (S+VCS)
Number of subjects: 605
Study 32990633 — intervention group
Group type: COMPARATOR
Intervention: Participants who completed postquestionnaire (S)
Number of subjects: 605
Study 32990633 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants who received their first preference in human support (S)
Number of subjects: 605
Study 33395401 — intervention group
Group type: EXPERIMENTAL
Intervention: Undersized drilling
Number of subjects: 30
Study 33395401 — intervention group
Group type: COMPARATOR
Intervention: Conventional drilling
Number of subjects: 30
Study 32962593 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg.kg‐1 ketamine (group K1)
Number of subjects: 75
Study 32962593 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg.kg‐1 ketamine (group K2)
Number of subjects: 75
Study 32962593 — intervention group
Group type: COMPARATOR
Intervention: Saline (group S)
Number of subjects: 75
Study 36042460 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic thoracentesis (TT)
Number of subjects: 10
Study 36042460 — intervention group
Group type: COMPARATOR
Intervention: Chest tube insertion (control)
Number of subjects: 10
Study 33589705 — intervention group
Group type: EXPERIMENTAL
Intervention: Underweight BMI
Number of subjects: 1273
Study 33589705 — intervention group
Group type: EXPERIMENTAL
Intervention: Overweight/obese BMI
Number of subjects: 1273
Study 33589705 — intervention group
Group type: COMPARATOR
Intervention: Normal weight BMI
Number of subjects: 1273
Study 33237965 — intervention group
Group type: EXPERIMENTAL
Intervention: Substance use (khat)
Number of subjects: 352
Study 33237965 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking
Number of subjects: 352
Study 33237965 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 352
Study 33237965 — intervention group
Group type: EXPERIMENTAL
Intervention: Never discussing safe sex with partner
Number of subjects: 352